Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...

Revenue $2.91 billion $2.78 billion $2.52 billion 15.7% Net Income (non-GAAP) $1.04 billion N/A $1.10 billion (5.5%) R&D and SG&A expenses (non-GAAP) $1.21 billion N/A $984 million 22.9% Vertex ...

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...

One week from tonight, the 2025 Formula 1 season will begin in unprecedented fashion. With the upcoming 2025 F1 season marking the 75th in the history of the sport, the year will begin with the ...

You’ve read the headlines about getting a REAL ID before the May 7 deadline. You’ve done your due diligence and made an appointment. Now what? What even is a REAL ID? It will be needed in ...

Unified Pension Scheme: Pension for govt employees with less than 25 years – Formula explained! (Image: Freepik) Unified Pension Scheme: The Finance Ministry issued a notification on January 24 ...

Your browser does not support the audio element. Pit stops are returning to Formula E after seven years. However, rather than a battery change, the new ‘Pit Boost ...

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

"Trade wars are good, and easy to win," Donald Trump said in 2018 – and he has begun his second term launching one against China. But until relatively recently, most of the world was in a ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...